Posted today in FDA Alerts

Lorazepam Oral Concentrate, USP 2mg/mL by Amneal Pharmaceuticals: Recall - Misprinted Dosing Droppers

ISSUE: Amneal Pharmaceuticals LLC is voluntarily recalling 13 lots of Lorazepam Oral Concentrate, USP 2mg/mL, to the Consumer level due to a defect in the dropper markings. The Lorazepam Oral Concentrate, USP 2mg/mL, product is packaged with a dosing dropper, supplied to Amneal by a third party. In a few instances, the dropper is printed with the dose...

Posted today in Medical

Pricey Wines Can Trick Your Brain

If you enjoy expensive wines, keep the findings of new brain research in mind: Your pleasure may have more to do with the price of the vino than its quality. "The reward and motivation system is activated more significantly with higher prices, and apparently increases the taste experience in this way," said researcher Bernd Weber. Weber is acting...

Posted today in Medical

Study Finds Options to Opioid Use After Knee Surgery

Alternative drug-free interventions to manage pain, including acupuncture and electrotherapy, may help reduce the need for prescription painkillers after knee replacement surgery, a new review suggests. "As prescription opioid use is under national scrutiny and because surgery has been identified as an avenue for addiction, it is important to recognize...

Posted yesterday in Clinical Trials

ARCA Biopharma Announces Completion of Enrolment for GENETIC-AF Phase 2B Clinical Trial Evaluating Gencaro (bucindolol hydrochloride)

ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced the completion of enrolment for GENETIC-AF, a Phase 2B, double-blind, superiority clinical trial evaluating Gencaro (bucindolol hydrochloride) as a potential...

Posted today in Medical

Hospitals Not to Blame for Most Opioid Addiction: Study

Painkiller prescriptions that lead to prolonged opioid use tend to be written by doctors in outpatient settings, not hospitals, new research indicates. Initial use of opioids such as OxyContin (oxycodone) and Vicodin (hydrocodone) is most often tied to spine and orthopedic disorders, but not surgery, said researcher and orthopedic surgeon Dr. Andrew...

Posted today in Medical

Can a Blood Test Detect a Range of Cancers Earlier?

A new genetic blood test might pave the way for detecting early stage cancers that often prove fatal when caught too late, a new study suggests. The test scans blood for DNA fragments released by cancerous tumors, explained lead researcher Dr. Victor Velculescu. By reviewing these DNA fragments for mutations found in 58 "cancer-driver" genes, the...

Posted today in Medical

Americans Injuring Themselves Grooming Pubic Hair

Should you consider trimming or shaving "down there," proceed with care -- a new study finds injuries tied to pubic hair grooming are more common than you might think. Cuts, burns and infections are reported more than a quarter of the time, according to the online survey of more than 7,500 U.S. adults. "In another study, we found that 3 percent of...

Posted today in Medical

Nearly 4 Million Worldwide Die Each Year From Asthma, COPD

Two major chronic lung diseases -- asthma and COPD -- kill nearly 4 million people worldwide annually, a new report finds. The study calculates that 3.2 million people died in 2015 from COPD (chronic obstructive pulmonary disease) -- a group of lung conditions that includes emphysema and chronic bronchitis, often tied to smoking. Asthma caused another...

Posted today in Medical

FDA Announces Recall of Some Liquid Pharmaceutical Products

The U.S. Food and Drug Administration has announced a recall of numerous liquid pharmaceutical products because of possible bacterial contamination that could cause severe infections in vulnerable patients. The drugs and dietary supplements, made by PharmaTech LLC in Davie, Fla., include liquid stool softeners, liquid vitamin D drops and liquid multivitamins...

Posted today in Medical

Powerful New Cholesterol Med Won't Harm Memory, Easing Concerns

Despite some early concerns, a new study suggests the powerful cholesterol drugs known as PCSK9 inhibitors may not cause memory problems or other mental symptoms. The drugs, which include evolocumab (Repatha) and alirocumab (Praluent), were approved in the United States in 2015. That came after trials showed they can dramatically slash LDL cholesterol...

Recently added consumer and prescribing information: Mavyret, Idhifa, Vosevi, Nerlynx, Tremfya, Bevyxxa, Rituxan Hycela, Baxdela, Imfinzi, Radicava

Posted in Blog

Drugs.com Recognized as ‘Health Information Website Brand of the Year’ in 2017 Harris Poll EquiTrend® Study

The team at Drugs.com is humbled and heartened to have been recognized as the ‘Health Information Website Brand of the Year‘ in the 2017 Harris Poll EquiTrend Study. The annual Harris Poll EquiTrend® Study measures and compares a brand’s health over time and against key competitors. Other categories measured include travel, financial, automotive and entertainment. […]

Posted in Blog

REMS@FDA: An Upgraded Patient Safety Program

REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]

Posted in Blog

Drugs.com the First Major Consumer Health Publisher to Implement Full HTTPS Encryption

Drugs.com is pleased to announce the introduction of full HTTPS encryption for all web site visitors. With this significant and important change, nearly 70 million monthly visitors will have access to critical health and medicine information in a safe, secure and private environment. Why HTTPS Encryption? Almost everything you do on the Internet leaves a digital […]